F.M.J. Debruyne

1 ta ish

Radboud University Nijmegen

1. Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia

   F.M.J. Debruyne, A A Gres, D. Arustamov

   MaqolaUrinary Bladder and Prostate ResearchEuropean Urology20081 iqtibos

   ABIABI:AkademIndex/2008.article.000044